A case-control study on the effects of the apolipoprotein e genotypes in nonalcoholic fatty liver disease

Molecular Biology Reports

Volumn 39, Issue 7, 2012, Pages 7381-7388

  De Feo, Emma ^a   Cefalo, Consuelo ^b   Arzani, Dario ^a   Amore, Rosarita ^a   Landolfi, Raffaele ^b   Grieco, Antonio ^b   Ricciardi, Walter ^a   Miele, Luca ^b   Boccia, Stefania ^a,c  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Alcohol; ApoE; Fruit and vegetables intake; Liver disease; NAFLD; Polymorphism

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; APOE EPSILON 2 GENE; APOE EPSILON 3 GENE; APOE EPSILON 4 GENE; APOE GENE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERCHOLESTEROLEMIA; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; POPULATION GENETICS; SEX DIFFERENCE;

ADULT; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED;

LONCHOCARPUS GLAUCIFOLIUS;

EID: 84864286804     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1570-7     Document Type: Article

References (29)

1. Enjoji M, Nakamuta M (2010) Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? World J Gastroenterol 16(7):800-803
2. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363(14):1341-1350
3. Hijona E, Hijona L, Arenas JI and Bujanda L (2010) Inflammatory mediators of hepatic steatosis. Mediators Inflamm. doi: 10.1155/2010/837419
4. Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24(5):695-708
5. Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, Day CP and Reeves HL (2008) The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastro-enterology 35(1):282-291
6. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennac-chio LA, Boerwinkle E, Cohe JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461-1465
7. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Konigsrainer I, Konigsrainer A, Schick F, Fritsche A, Haring HU, Stefan N (2009) Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phos-pholipase 3 gene. Diabetes 58:2616-2623
8. Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H (2009) A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52:1056-1060 9.
9. Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ (2009) A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 50:2111-2116
10. Sookoian S, Pirola CJ (2011) Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53(6):1883-1894
11. Moore LE, Brennan P, Karami S (2009) Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res 69: 8001-8008
12. Mahley RW, Nathan BP, Pitas RE (1996) Apolipoprotein E: structure function and possible roles in Alzheimer's disease. Ann N Y Acad Sci 777:139-145
13. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298:1300-1311 (Pubitemid 47443344)
14. Demirag MD, Onen HI, Karaoguz MY, Dogan I, Karakan T, Ekmekci A, Guz G (2007) Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease. Dig Dis Sci 52(12):3399-3403 (Pubitemid 350077186)
15. Yang MH, Son HJ, Sung JD, Choi YH, Koh KC, Yoo BC, Paik SW (2005) The relationship between apolipoprotein E polymorphism lipoprotein (a) and fatty liver disease. Hepatogastroenter-ology 52(66):1832-1835 (Pubitemid 41745641)
16. Lee DM, Lee SO, Mun BS, Ahn HS, Park HY, Lee HS, Kim DG (2002) Relation of apolipoprotein E polymorphism to clinically diagnosed fatty liver disease. Taehan Kan Hakhoe Chi 8(4): 355-362 (Article in Korean)
17. Day CP (2010) Genetic and environmental susceptibility to nonalcoholic fatty liver disease. Dig Dis 28(1):255-260
18. Seripa D, Signori E, Gravina C, Matera MG, Rinaldi M, Fazio VM (2006) Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Pathol 15(3):180-185 (Pubitemid 44325481)
19. Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) National cholesterol education program: executive summary of the third report of the national cholesterol education program (NCEP). JAMA 285:2486-2497
21. Brunt EMJC, Di Bisceglie AM, Neuschwander-Tetri BA et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 2467-2474 (Pubitemid 29420675)
22. Cano A, Ciaffoni F, Safwat GM, Aspichueta P, Ochoa B, Bravo E, Botham KM (2009) Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q? J Appl Physiol 107(3):707-717
23. Mensenkamp AR, Havekes LM, Romijn JA, Kuipers F (2001) Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E. J Hepatol 35(6):816-822 (Pubitemid 34717676)
24. Kypreos K, van Dijk KW, van de Zee A, Havekes LM, Zannis VI (2001) Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyc-eride secretion. J Biol Chem 276:19778-19786
25. Dunn W, Xu R, Schwimmer JB (2008) Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47(6):1947-1954 (Pubitemid 351945562)
26. Djoussé L, Himali JJ, Beiser A, Kelly-Hayes M, Wolf PA (2009) Apolipoprotein e alcohol consumption and risk of ischemic stroke: the Framingham Heart Study revisited. J Stroke Cere-brovasc Dis 18(5):384-388
27. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH (2010) The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7(5): 251-264
28. Djoussé L, Pankow JS, Arnett DK, Eckfeldt JH, Myers RH, Ellison RC (2004) Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart Lung and Blood Institute Family Heart Study. Am J Clin Nutr 80(6):1639-1644 (Pubitemid 41103865)
29. Ioannidis JPA (2006) Meta-analysis in public health: potential and problems. Ital J Public Health 3:9-14